NeuroOne Medical NMTC 深 沪
等待开盘 11-13 09:30:00 美东时间
0.7474
-0.055
-6.85%
华盛通- 最 高0.8399
- 今 开0.80
- 成交量 5.92万股
- 最 低 0.745
- 昨 收 0.8024
- 总市值 680.56万
- 52周最高 6.12
- 市盈率 静 --
- 换手率 0.65%
- 52周最低 0.745
- 委 比 0.00%
- 总股本 910.58万
- 历史最高 47.82
- 量 比 1.27
- 振 幅 11.83%
- 历史最低 0.745
- 每 手 1
- 风险率 1.47%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NeuroOne Medical shares are trading higher after the company announced the publication of initial clinical results evaluating its OneRF Trigeminal Nerve Ablation System in the peer-reviewed journal Pain Management.
NeuroOne Medical shares are trading higher after the company announced the publication of initial clinical results evaluating its OneRF Trigeminal Nerve Ablation System in the peer-reviewed journal Pain Management.
10-30 00:33
NeuroOne Secures First Pharmaceutical Industry Purchase Order For StereoCED Drug Delivery Platform; No Terms Disclosed
Major Commercial Milestone Represents Important Step Toward Potential Long-Term Collaborations with Global Pharmaceutical Companies EDEN PRAIRIE, Minn., Oct. 22, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology compa...
10-22 20:35
NeuroOne Reports Strong Fiscal 2026 Revenue Growth
NeuroOne Medical Technologies ( ($NMTC) ) just unveiled an announcement. On Oct...
10-05 21:40
NeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, today announced preliminary, unaudited product revenue for its fourth fiscal quarter and full ...
10-05 21:21
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
NeuroOne Medical Technologies reported preliminary Q4 2026 product revenue of $3.8 million, up 38.4% YoY, and full-year revenue of $10.5 million, a 15.6% increase, hitting the top of its guidance. The company secured a record $4.5 million order in September, with $1.0 million shipped and the remainder expected in Q1 and Q2 2027. CEO Dave Rosa highlighted a 24.2% YoY increase in product orders and strong positioning for 2027 with $5.4 million in o...
10-05 13:17
NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement
NeuroOne Medical Technologies has signed a new Southern California distribution agreement for its OneRF® Trigeminal Nerve Ablation System, expanding commercial access in key U.S. markets, including the Los Angeles metropolitan area. The system, FDA-cleared for treating trigeminal neuralgia, offers a minimally invasive radiofrequency ablation option. The agreement supports NeuroOne's strategy to build a distribution network across key U.S. markets...
09-17 13:05
NeuroOne Completes Three Large-Animal StereoCED Procedures, Including Combined Drug Delivery And Brain Recording; Builds Momentum Toward Planned Launch Of The StereoCED Platform For Human Investigational Clinical Studies Later This Quarter
Successful Large-Animal Procedures Build Momentum Toward Planned Launch of the StereoCED™ Platform for Human Investigational Clinical Studies Later This Quarter Related StereoCED™ Revenue Expected to be Recognized in the Current Fiscal Quarter EDEN PRAIRIE, Minn. – August 27, 2026 – NeuroOne Med...
08-27 21:08
美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
Maxim Group Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $5
Maxim Group analyst Anthony Vendetti maintains NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy and lowers the price target from $13 to $5.
08-15 04:24
NeuroOne (NMTC) 2026财年第三季度业绩电话会议：订单增长43%，利润率达59.9%
NeuroOne 2026财年第三季度财报电话会议介绍了16%的营收增长、59.9%的毛利率、270万美元的订单，以及受产能限制的业绩指引。
08-14 08:31
